Robert V. Baumgartner's most recent trade in Bio-Techne Corp was a trade of 3,511 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Oct. 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne Corp | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 3,511 | 3,511 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 1,462 | 44,863 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.95 per share. | 08 Aug 2024 | 16,000 | 59,401 (0%) | 0% | 23.0 | 367,200 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 16,000 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Sale of securities on an exchange or to another person at price $ 72.10 per share. | 08 Aug 2024 | 16,000 | 43,401 (0%) | 0% | 72.1 | 1,153,664 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 865 | 865 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 338 | 10,444 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Purchase of securities on an exchange or from another person at price $ 352.55 per share. | 10 May 2022 | 300 | 10,106 (0%) | 0% | 352.6 | 105,765 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 633 | 633 | - | - | Stock Options (right to buy) | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 194 | 9,806 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 4,000 | 0 | - | - | Stock Options (right to buy) | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.39 per share. | 23 Aug 2021 | 4,000 | 13,612 (0%) | 0% | 87.4 | 349,560 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Sale of securities on an exchange or to another person at price $ 486.25 per share. | 23 Aug 2021 | 1,600 | 10,512 (0%) | 0% | 486.3 | 778,004 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Sale of securities on an exchange or to another person at price $ 487.10 per share. | 23 Aug 2021 | 800 | 9,712 (0%) | 0% | 487.1 | 389,682 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Sale of securities on an exchange or to another person at price $ 483.60 per share. | 23 Aug 2021 | 601 | 12,712 (0%) | 0% | 483.6 | 290,643 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Sale of securities on an exchange or to another person at price $ 485.02 per share. | 23 Aug 2021 | 600 | 12,112 (0%) | 0% | 485.0 | 291,015 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Sale of securities on an exchange or to another person at price $ 481.77 per share. | 23 Aug 2021 | 299 | 13,313 (0%) | 0% | 481.8 | 144,050 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Sale of securities on an exchange or to another person at price $ 487.88 per share. | 23 Aug 2021 | 100 | 9,612 (0%) | 0% | 487.9 | 48,788 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2020 | 5,000 | 0 | - | - | Stock Options (right to buy) | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.90 per share. | 18 Nov 2020 | 5,000 | 14,612 (0%) | 0% | 66.9 | 334,500 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Sale of securities on an exchange or to another person at price $ 303.34 per share. | 18 Nov 2020 | 5,000 | 9,612 (0%) | 0% | 303.3 | 1,516,675 | Common Stock |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 1,507 | 1,507 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne Corp | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 391 | 9,612 (0%) | 0% | 0 | Common Stock |